Jane P Genido-trujillo, MS,APRN Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 230 Waterford Pkwy S, Waterford, CT 06385 Phone: 860-444-3744 |
Alexandra Lamonica, MSN, RN, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 196 Waterford Pkwy S, Waterford, CT 06385 Phone: 860-443-4455 |
Patricia Mcclure, APRN, PMH-NP BC Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7 Mayfair Dr, Waterford, CT 06385 Phone: 860-442-6567 Fax: 860-440-3620 |
Deborah Lynn Selm-orr, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 230 Waterford Pkwy S, Waterford, CT 06385 Phone: 860-444-3744 |
Jessie R Baudner, ANP BC Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 196 Waterford Pkwy S Ste 306, Waterford, CT 06385 Phone: 860-447-2489 Fax: 860-437-1231 |
News Archive
Ampio Pharmaceuticals, Inc., announced it has received approval for a new stock trading symbol from FINRA Operations. Effective March 31, 2010, Ampio Pharmaceuticals, Inc. will trade under the symbol "AMPE," and Ampio's common stock will carry a new CUSIP number, 03209T 109. The symbol change follows the March 24 change in the company's corporate name from Chay Enterprises, Inc. to Ampio Pharmaceuticals, Inc., and its reincorporation in Delaware.
Over the next five years, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, will award approximately $20 million to four academic centers to launch a new national Career Development Consortium for Excellence in Glycosciences.
People who live in areas with lower household incomes are much more likely to die because of their personal and household characteristics and their community surroundings, according to Steven H. Woolf, M.D., M.P.H., director of the VCU Center on Human Needs, professor in the Department of Family Medicine and lead author of the study.
In preliminary results, researchers have shown that a drug which mimics the effects of the nerve-signaling chemical dopamine causes new neurons to develop in the part of the brain where cells are lost in Parkinson's disease (PD).
› Verified 4 days ago